Poulvac® Procerta® HVT-IBD
Vector live frozen vaccine against Marek's disease and infectious bursal disease
Modified live vector frozen vaccine
Recombinant HVT serotype 3 with IBD virus VP2 gene
In ovo (18–19 days) or subcutaneous injection to day-old chicks
Available as
Frozen vaccine
For use with
Poultry (chickens)
Strength
Recombinant HVT-3 (IBD VP2 gene)
How it is supplied
5 × 4,000 doses
Drug description
Vector Vaccine POULVAC® PROCERTA® HVT-IBD
Poulvac® Procerta® HVT-IBD is a modified live vector frozen vaccine. Composition: frozen cell-associated live viral vaccine containing recombinant turkey herpesvirus serotype 3 with the VP2 gene of infectious bursal disease virus.
Demonstrated efficacy for vaccination of healthy day-old chicks or in ovo vaccination of 18–19-day embryonated chicken eggs against Marek's disease and infectious bursal disease.
Route of administration: in ovo or subcutaneous injection. Packaging: 5 × 4,000 doses.
Contact us
Start cooperation with industry leaders
